
"$ECOR: VA channel GammaCore sales up 85% YoY with just migraine/cluster headache indications. $40M market cap at <2x sales with 57% YoY growth, 85% margins. FDA catalysts coming: PTSD, Parkinson's, etc. could accelerate TAM expansion. Still unprofitable but strong runway ahead."
Tailwinds Yeehee - electroCore, Inc.
haYN Capital
April 22, 2025
Stock Idea